Table 8.
Items | CON | XY | Value of p |
---|---|---|---|
day 7 | |||
Epidermal growth factor, pg./mg | 23.45 ± 3.02 | 18.10 ± 0.26 | 0.217 |
Glucagon-like peptide-1, pmol/g | 0.69 ± 0.04 | 0.89 ± 0.08 | 0.098 |
Glucagon-like peptide-2, pg./mg | 200.70 ± 26.26 | 156.50 ± 7.41 | 0.181 |
Insulin-like growth factor-1, ng/mg | 17.43 ± 1.36 | 21.95 ± 1.53 | 0.093 |
day 14 | |||
Epidermal growth factor, pg./mg | 21.37 ± 2.27 | 18.66 ± 1.98 | 0.420 |
Glucagon-like peptide-1, pmol/g | 0.71 ± 0.02 | 0.99 ± 0.12 | 0.141 |
Glucagon-like peptide-2, pg./mg | 153.20 ± 4.77 | 153.20 ± 22.33 | 1.000 |
Insulin-like growth factor-1, ng/mg | 17.17 ± 0.19 | 22.39 ± 2.34 | 0.157 |
day 21 | |||
Epidermal growth factor, pg./mg | 25.34 ± 1.36 | 24.57 ± 7.26 | 0.926 |
Glucagon-like peptide-1, pmol/g | 0.73 ± 0.02 | 1.12 ± 0.15 | 0.118 |
Glucagon-like peptide-2, pg./mg | 201.70 ± 12.91 | 213.10 ± 12.73 | 0.843 |
Insulin-like growth factor-1, ng/mg | 16.87 ± 1.45 | 28.68 ± 4.72 | 0.075 |
day 42 | |||
Epidermal growth factor, pg./mg | 21.21 ± 7.87 | 24.53 ± 2.00 | 0.703 |
Glucagon-like peptide-1, pmol/g | 1.08 ± 0.34 | 0.88 ± 0.09 | 0.600 |
Glucagon-like peptide-2, pg./mg | 181.70 ± 6.71 | 194.70 ± 4.87 | 0.853 |
Insulin-like growth factor-1, ng/mg | 21.17 ± 7.84 | 22.24 ± 1.71 | 0.905 |
CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Values are expressed as means ± SEM, n = 6.